Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
A new clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia. Here’s how to get more info.
Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
Removing naive T cells before a stem cell transplant in certain cancer patients may prevent chronic graft-versus-host disease.
The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.
More than two-thirds of patients with blood cancer who experienced septic shock died within 28 days, finds MD Anderson Cancer Center.
New guidelines from NCCN offer clarity and consensus on how best to address and treat a common side effect of stem cell transplants.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.
The procedure can put certain blood cancers into remission and may lead to a cure.
Brian Koffman, a family physician when diagnosed with chronic lymphocytic leukemia, cofounded the CLL Society.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.